Relative contribution of individual oxidized components in ox-LDL to inhibition on endothelium-dependent relaxation in rat aorta

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 3, 2011, Pages 157-164

  Wong, W T ^a   Ng, C H ^a   Tsang, S Y ^a   Huang, Y ^a   Chen, Z Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

RATTUS;

EID: 79951509868     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2008.12.017     Document Type: Article

References (34)

1. Tabata T., Mine S., Kawahara C., Okada Y., Tanaka Y. Monocyte chemoattractant protein-1 induced scavenger receptor expression and monocyte differentiation into foam cell. Biochem Biophys Res Commun 2003, 305:380-385.
2. Taguchi S., Oimuma T., Yamada T. A comparative study of cultured smooth muscle cell proliferation and injury, utilizing glycated low density lipoproteins with slight oxidation, antu-oxidation, or extensive oxidation. Atheroscler Thromb 2000, 7:132-137.
3. Boudjeltia K.Z., Legssyer I., van Kisoka R.L., Babar S., Moguilevsky N., Delree P., et al. Triggering of inflammatory response by myeloperoxidase-oxidized LDL. Biochem Cell Biol 2006, 84:805-812.
4. Murugesan G., Fox P.L. Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein. J Clin Invest 1996, 97:2736-2744.
5. Heermeier K., Leicht W., Palmetshofer A., Ullrich M., Wanner C., Galle J. Oxidized LDL suppresses NF-kappaN and overcomes protection from apoptosis in activated endothelial cells. J Am Soc Nephrol 2001, 12:456-463.
6. Dimmeler S., Haendeler J., Galle J., Zeiher A.M. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like protease. A mechanistic clue to the "response to injury" hypothesis. Circulation 1997, 95:1760-1763.
7. Ann M., Paul H. Oxidized LDL and HDL: antagonist in atherosclerosis. FASEB J 2001, 15:2073-2084.
8. Shimokawa H., Flavanhan N.A., Vanhoutte P.M. Natural course of the impairment of endothelium-dependent relaxation after balloon endothelium removal in porcine coronary arteries: Possible dysfunction of a pertussis toxin-sensitive G protein. Circ Res 1989, 65:740-753.
9. Tanner F.C., Noll G., Boulanger C.M., Luscher T.F. Oxidized low-density lipoproteins inhibits relaxation of porcine coronary arteries: Role of scavenger receptor and endothelium-derived nitric oxide. Circulation 1991, 83:2012-2020.
10. Kumar N., Shingal O.P. Effect of processing conditions on the oxidation of cholesterol in ghee. J Sci Food Agric 1992, 58:267-273.
11. Escharte M., Zulet M.A., Astiasaran I. Oxidation process affecting fatty acids and cholesterol in fried and roasted salmon. J Agric Food Chem 2001, 49:5662-5667.
12. Smith L. Cholesterol autoxidation. Chem Phys Lipids 1987, 44:87-125.
13. Osada K., Komada T., Cui L., Yamada K., Sugano M. Level and formation of oxidized cholesterols in processed marine foods. J Agric Food Chem 1993, 41:1893-1898.
14. Tai C.Y., Chen Y.C., Chen B.H. Analysis, formation and inhibition of cholesterol oxidation products in foods: an overview (part II). J Food Drug Anal 2000, 8:1-15.
15. Staprans I., Pan X.M., Rapp J.H., Feingold K.H. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis. Mol Nutr Food Res 2005, 49:1075-1082.
16. Staprans H., Pan X.M., Joseph H.R., Feingold K.R. Oxidized cholesterol in the diet accelerates the development of aortic atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 1998, 18:977-983.
17. Staprans H., Pan X.M., Joseph H.R., Grunfeld C., Feingold K.R. Oxidized cholesterol in the diet accelerates the development of aortic atherosclerosis in LDL-receptor and apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2000, 20:708-714.
18. Kugiyama K., Kerns S.A., Morrisett J.D., Roberts R., Henry P.D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoprotein. Nature 1990, 344:160-161.
19. Yokoyama M., Hirata K.I., Muyake R., Akita H., Ishikawa Y., Fukuzaki H. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low-density lipoprotein. Biochem Biophys Res Commun 1990, 168:301-308.
20. Zhao L., Tackett R.L. Oxidized low-density lipoprotein inhibits acetylcholine-induced vasorelaxation and increases 5-HT-induced vasoconstriction in isolated human saphenous vein. J Pharmacol Exp Ther 1998, 284:637-643.
21. Chan H., Lougheed M., Laher I., Steinbrecher U.P. Oxidized low-density lipoprotein inhibits endothelium-dependent vasodilation by an antioxidant-sensitive, lysophosphatidylcholine-independent mechanism. J Cardiovasc Pharmacol 2003, 41:856-865.
22. Mangin E.L., Kugiyama K., Nguy J.H., Kerns S.A., Henry P.D. Effects of lysolipids and oxidatively modified low-density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ Res 1993, 72:161-166.
23. Hodis H.N., Crawford D.W., Sevanian A. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis 1991, 89:117-126.
24. Carpenter K.L.H., Taylor S.E., Ballantine J.A., Fussell B., Halliwell B., Mitchinson M.J. Lipids and oxidized lipids in human atheroma and normal aorta. Biochim Biophys Acta 1993, 1167:121-130.
25. Deckert V., Persegol L., Viens L., Lizard G., Athias A., Lallemant C., et al. Inhibitors of arterial relaxation among compounds of human oxidized low-density lipoproteins. Cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation. Circulation 1997, 95:723-731.
26. Pomposiello S.I., Alva M., Wilde D.W., Carretero O.A. Linoleic acid induces relaxation and hyperpolarization of the pig coronary artery. Hypertension 1998, 31:615-620.
27. Christon R., Marette A., Badeau M., Bourgoin F., Melancon S., Bachelard H. Fatty acid-induced changes in vascular reactivity in healthy adult rats. Metabolism 2005, 54:1600-1609.
28. Myers P.R., Wright T.F., Tanner M.A., Ostlund R.E. The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium. J Lab Clin Med 1994, 124:672-683.
29. Koul A., Singh A., Sandhit R. Effect of alpha-tocopherol on the cardiac antioxidant defence system and atherogenic lipids in cigarette smoke-inhaling mice. Inhal Toxicol 2004, 15:513-522.
30. Amann K., Tornig J., Buzello M., Kuhlmann A., Grosss M.L., Adamczak M., et al. Effect of antioxidant therapy with dl-alpha-tocopherol on cardiovascular structure in experimental renal failure. Kidney Int 2002, 62:877-884.
31. Cheng X., Cui Y., Chen Y., Zhang X. Effect of alpha-tocopherol and beta-carotene on the oxidized low density lipoprotein induced by Cu2+. Wei Sheng Yan Jiu 2000, 29:229-231.
32. Devaraj S., Jialal I. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation. Circulation 2000, 102:191-196.
33. Thomas S.R., Stocker R. Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis. Free Radic Biol Med 2000, 28:1795-1805.
34. van Aalst J.A., Burmeister W., Fox P.L., Graham L.M. Alpha-tocopherol preserves endothelial cell migration in the presence of cell oxidized low-density lipoprotein by inhibiting changes in cell membrane fluidity. J Vasc Surg 2004, 39:229-237.